Viewing Study NCT01194050


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-28 @ 8:54 PM
Study NCT ID: NCT01194050
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2010-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module